Position in CDXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$22,200
+$0 QoQ
Shares Held
13,620
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Fiduciary Trust Co holds $26,836,623 across 28 Biotechnology names. CDXS ranks #26 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,876 | $8,875,428 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,478 | $6,550,441 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
17,898 | $1,740,580 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
8,541 | $1,614,675 | |
| 5 | VYGR |
Voyager Therapeutics, Inc.
|
334,397 | $1,290,772 | |
| 6 | FULC |
Fulcrum Therapeutics, Inc.
|
136,555 | $1,047,376 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
7,959 | $591,035 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
7,399 | $555,590 |
All Filings in CDXS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,200 | 13,620 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,200 | 13,620 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $33,232 | 13,620 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $33,232 | 13,620 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $36,637 | 13,620 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $64,967 | 13,620 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||